This review evaluates the safety profile of glucagon-like peptide-1 receptor agonists and related incretin therapies used for obesity and type 2 diabetes. It highlights common gastrointestinal effects ...

Early trials, according to The New York Times, have shown that people with obesity and knee osteoarthritis lost 28.7 percent of their body weight after taking the highest dose for nearly 70 weeks, ...

The Better Business Bureau is sounding the alarm about what it’s calling a troubling trend of deep fake videos promoting ...

Many high-protein, low-carb foods, such as meat, nuts, and seeds, can help you with your health goals. Here are top options to consider.

Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

Intermittent fasting has become one of the most talked-about weight loss trends in recent years, promising dramatic results ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Feb 10 (Reuters) - U.S.-based Kailera Therapeutics and its partner Jiangsu Hengrui Pharmaceuticals said on Tuesday their experimental oral obesity drug helped patients lose up to 12.1% body weight at ...

Breaking new science reveals how a specific fiber can decrease liver fat synthesis, increase fat burning, and even turn sugar into proteins. But that's only the ...

If compounded and generic GLP-1 drugs work as well as brand-name versions, they could fill a significant void by offering ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

Airlines stand to save a potential $580 million as travelers slim down thanks to the effects of weight-loss drugs, a new study found. Sheila Kahyaoglu, an equity analyst at Jefferies and an author of ...